Libervant™ (diazepam) – New drug approval
April 26, 2024 - The FDA approved Aquestive Therapeutics’ Libervant (diazepam) buccal film, for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (ie, seizure clusters, acute repetitive seizures) that are distinct from a patient’s usual seizure pattern in patients with epilepsy 2 to 5 years of age.